Table 3.
Antigen |
No. of subjects |
Test | Sensitivity (%) | Specificity (%) | Cross reactions | Year | Ref. | ||
CE patients | Other disease | Healthy control | |||||||
nAg B | 204 | 21 | 90 | IB | 66 | 100 | None | 2000 | [75] |
nAg B | 59 | 55 | 15 | IgG ELISA | 80 | 77 | AE, NCC | 2005 | [77] |
nAg B | 90 | 86 | 27 | IgG ELISA | 77 | 85 | AE, RA | 2000 | [9] |
nAg B | 204 | 21 | 90 | IgG ELISA | 74 | 100 | None | 2000 | [75] |
nAg B | 31 | 87 | 29 | IgG ELISA | 77.41 | 81.9 | AE, Ev, Schist, Toxoc | 2000 | [78] |
nAg B | 78 | 24 | 15 | IgG ELISA | 93.5 | 89.7 | Distomatosis, Schist | 2001 | [71] |
nAg B | 129 | 65 | 203 | IgG ELISA | 60.3 | 92.6 | Cysts,Toxoc | 2003 | [44] |
nAg B | 22 | 12 | 4 | WB | 77 | 100 | Toxoc, Other cestodes | 2010 | [30] |
nAg B | 40 | 40 | 70 | IgG ELISA | 92.5 | 97.3 | Fascio | 2007 | [10] |
nAg B | 40 | 40 | 70 | CCIEP | 97.5 | 58.2 | Fascio, Toxoc, Taenia, Malignancy | 2007 | [10] |
nAg B | 204 | 53 | 90 | IB | 66 | 100 | None | 2000 | [75] |
nAg B | 204 | 53 | 90 | IgG ELISA | 74 | 100 | None | 2000 | [75] |
nAg B | 35 | 29 | 25 | IgG ELISA | 94.2 | 81.6 | NR | 2009 | [16] |
nAg B | 55 | 72 | 50 | IgG ELISA | 96.4 | 97.2 | None | 2014 | [68] |
nAg B | 113 | 112 | 121 | DIGFA | 92.9 | 81 | HD, Cysts, HCC, HH | 2015 | [48] |
Goat liver Ag B | 47 | 30 | 40 | IgG ELISA | 91.4 | 92.8 | NR | 2011 | [49] |
Human liver Ag B | 47 | 30 | 40 | IgG ELISA | 97.8 | 97.1 | NR | 2011 | [49] |
Bovine lung Ag B | 47 | 30 | 40 | IgG ELISA | 78.7 | 85.7 | NR | 2011 | [49] |
Sheep lung Ag B | 47 | 30 | 40 | IgG ELISA | 93.6 | 88.5 | NR | 2011 | [49] |
Camel lung Ag B | 47 | 30 | 40 | IgG ELISA | 93.6 | 90 | NR | 2011 | [49] |
Sheep liver Ag B | 47 | 30 | 40 | IgG ELISA | 95.7 | 92.8 | NR | 201 | [49] |
rAgB | 204 | 21 | 90 | IB | 72 | 100 | None | 2000 | [75] |
rAgB | 113 | 112 | 121 | DIGFA | 77.9 | 98.3 | None | 2015 | [48] |
rAgB8/1 | 31 | 87 | 29 | IgG ELISA | 54.84 | 80.17 | AE, Schist, Toxoc | 2000 | [78] |
rAgB8/1 | 129 | 65 | 203 | IgG4 ELISA | 91.4 | 91.7 | Cysts | 2003 | [44] |
rAgB8/1 | 59 | 55 | 15 | IgG ELISA | 68 | 88 | AE, NCC | 2005 | [80] |
rAgB8/2 | 31 | 87 | 29 | IgG ELISA | 83.87 | 98.28 | Schist, Toxoc | 2000 | [78] |
rAgB8/2 | 129 | 65 | 203 | IgG ELISA | 93.1 | 99.5 | Cysts, Toxoc | 2003 | [45] |
rAgB8/2 | 129 | 65 | 203 | IgG4 ELISA | 69 | 87.5 | Cysts | 2003 | [45] |
rAgB8/2 | 59 | 55 | 15 | IgG ELISA | 45 | 86 | AE, NCC | 2005 | [77] |
rAgB8/1 | 129 | 65 | 203 | IgG4 ELISA | 91.4 | 91.7 | Cysts | 2003 | [44] |
rAgB8/1 | 59 | 55 | 15 | IgG ELISA | 68 | 88 | AE, NCC | 2005 | [77] |
rAgB8/2 | 31 | 87 | 29 | IgG ELISA | 83.87 | 98.28 | Schist, Toxoc | 2000 | [78] |
rAgB8/2 | 129 | 65 | 203 | IgG ELISA | 93.1 | 99.5 | Cysts, Toxoc | 2003 | [44] |
rAgB8/2 | 129 | 65 | 203 | IgG4 ELISA | 69 | 87.5 | Cysts | 2003 | [44] |
rAgB8/2 | 59 | 55 | 15 | IgG ELISA | 45 | 86 | AE, NCC | 2005 | [77] |
B1t | 102 | 68 | 95 | IgG ELISA | 83.3 | 87.5 | AE, Schist, Cysts, Fascio, | 2008 | [9] |
B2t | 102 | 68 | 95 | IgG ELISA | 91.2 | 93 | Cysts, Schist, Fascio | 2008 | [9] |
2B2t | 186 | 174 | 110 | IgG ELISA | 87.6 | 99.1 | AE, NCC, Hepatitis | 2012 | [9] |
rEgAFFPt | 129 | 65 | 203 | IgG ELISA | 58.6 | 95.6 | Cysts, Toxoc | 2003 | [44] |
rEgCaBP2 | 129 | 65 | 203 | IgG ELISA | 84.5 | 96.6 | Cysts, Toxoc | 2003 | [44] |
rEgcMDH | 129 | 65 | 203 | IgG ELISA | 89.7 | 95.1 | Cysts | 2003 | [44] |
rEgAFFPf | 129 | 65 | 203 | IgG ELISA | 69 | 89.7 | Cysts, Toxoc | 2003 | [44] |
rEpC1-GST | 324 | 502 | 70 | IgG IB | 92.2 | 95.6 | AE, NCC, Schist, | 2003 | [79] |
Liver cancer | |||||||||
rTPxEg | 100 | 218 | 20 | IgG IB | 39 | 69.3 | AE, NCC | 2004 | [78] |
rEgG5 | 23 | 138 | 20 | IgG IB | 61 | 70 | AE, Cysts | 2004 | [79] |
E14t | 102 | 68 | 95 | IgG ELISA | 35.3 | 91.7 | Schist | 2008 | [9] |
C317 | 102 | 68 | 95 | IgG ELISA | 58.8 | 80.9 | AE, Cysts, Taeniasis, Schist, | 2008 | [9] |
p65 | 90 | 86 | 27 | IgG ELISA | 44 | 96 | AE, Schist, Toxoc | 2000 | [9] |
p175 | 90 | 86 | 27 | IgG ELISA | 49 | 94 | AE, Schist, Toxoc | 2000 | [9] |
p176 | 90 | 86 | 27 | IgG ELISA | 80 | 93 | AE, Schist, Toxoc, | 2000 | [9] |
Syph, Chagas | |||||||||
p177 | 90 | 86 | 27 | IgG ELISA | 38 | 92 | AE, Toxoc, Syph, | 2000 | [9] |
Chagas | |||||||||
pGu4 | 90 | 86 | 27 | IgG ELISA | 18 | 98 | AE | 2000 | [9] |
Leish: Leishmaniasis; Toxop: Toxoplasmosis; Fascio: Fascioliasis; Cysts: Cysticercosis; Ascaris: Ascariasis; Syph: Syphilis; Ambs: Amebiasis; Toxoc: Toxocariasis; Schist: Schistosomiasis; NCC: Neurocysticercosis; AE: Alveolar echinococcosis; nAg B: Native antigen B; rAgB: Recombinant antigen B; Ev: Ev: Polycistic hydatid disease (E. vogeli); RA: Rheumatoid arthritis; HCC: Hepatocellular carcinoma; NR: Not reported; CE: Cystic echinococcosis; ELISA: Enzyme-linked immunosorbent assay.